Hasil Pencarian - Tunde Tarr
- Menampilkan 1 - 12 hasil dari 12
-
1
-
2
-
3
Altered Circulating Follicular T Helper Cell Subsets and Follicular T Regulatory Cells Are Indicators of a Derailed B Cell Response in Lupus, Which Could Be Modified by Targeting I... oleh Krisztina Szabó, Ilona Jámbor, Kitti Pázmándi, Nikolett Nagy, Gábor Papp, Tünde Tarr
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel -
4
-
5
Clinical Features and Survival Analysis of Lupus Nephritis among Patients with Systemic Lupus Erythematosus: A Three-Decade-Long Retrospective Cohort Study oleh Bianka Perge, Gábor Papp, Bernadett Bói, Nikolett Nagy, Eszter Gáspár-Kiss, Tünde Tarr
Diterbitkan 2024-09-01Dapatkan teks lengkap
Artikel -
6
Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus oleh Ágnes Diószegi, Hajnalka Lőrincz, Eszter Kaáli, Pál Soltész, Bianka Perge, Éva Varga, Mariann Harangi, Tünde Tarr
Diterbitkan 2023-02-01Dapatkan teks lengkap
Artikel -
7
-
8
The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren’s Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution oleh Krisztina Szabó, Ilona Jámbor, Antónia Szántó, Ildikó Fanny Horváth, Tünde Tarr, Britt Nakken, Peter Szodoray, Gábor Papp
Diterbitkan 2021-03-01Dapatkan teks lengkap
Artikel -
9
MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome. oleh Ji-Qing Chen, Gábor Papp, Szilárd Póliska, Krisztina Szabó, Tünde Tarr, Bálint László Bálint, Péter Szodoray, Margit Zeher
Diterbitkan 2017-01-01Dapatkan teks lengkap
Artikel -
10
Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells oleh Dóra Bencze, Tünde Fekete, Walter Pfliegler, Árpád Szöőr, Eszter Csoma, Antónia Szántó, Tünde Tarr, Attila Bácsi, Lajos Kemény, Zoltán Veréb, Kitti Pázmándi
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel -
11
-
12
LO-021 Interim safety and efficacy of subcutaneous (s.c.) dose ianalumab (VAY736; anti-BAFF-R mAb) administered monthly over 28 weeks in patients with systemic lupus erythematosus... oleh Yuko Kaneko, Masato Okada, Stephanie Finzel, Nan Shen, Elena Vishneva, Lingyun Sun, Bernadette Rojkovich, Alberta Hoi, Shin-Seok Lee, Piotr Leszczyński, Lie Dai, Rafal Wojciechowski, Cheng-Chung Wei, Katarzyna Romanowska-Prochnicka, Hiroshi Kaneko, Stanislav Ignatenko, Alexander Gordienko, Josefina Hernandez, Nancy Levin, Pongthorn Narongroeknawin, Hanna Ciferska, Masanari Kodera, Joung Liang Lan, Tunde Tarr, Yi Hsing Chen, Ajchara Koolvisoot, Eugeny Zotkin, Berta Paula magallares, Tirtha Sengupta, Carole Sips, Stephan Oliver
Diterbitkan 2023-07-01Artikel